Navigation Links
Average Medicare Prescription Drug Premiums to Rise 21%
Date:10/5/2007

WASHINGTON, Oct. 5 /PRNewswire/ -- If consumers stay put in their current Medicare prescription drug plans, the average beneficiary will see a 21% increase in their monthly premiums for 2008, says new analysis released by Avalere Health.

Using newly released CMS data and its proprietary DataFrame(R) database, Avalere experts computed an "enrollment weighted" average premium for the Medicare Part D marketplace. Under this method, the premiums of plans with the most enrollees are assigned a heavier weight relative to plans with scant enrollment, giving a truer measure of the beneficiary experience. For example, a premium increase for a prescription drug plan (PDP) with 3 million enrollees carries vastly greater impact on more people than a premium increase for a plan with 10,000 enrollees.

"The reality of the Medicare experience is that beneficiaries have been very loyal thus far to their initial plan selections," said Dan Mendelson, president of Avalere Health. "If consumers stick to their choices again, they are likely to see a dramatic increase in their monthly premiums. But, consumers who shop around may be able to find lower cost alternatives."

The top ten PDP sponsors in Medicare have more than 80% of the people enrolled in stand-alone PDPs. Among those top ten plan sponsors, all have raised their premiums, with the exception of two: CVS Caremark's SilverScript plan and First Health's Part D Premier plan. Using Avalere's enrollment-weighted premium methodology, the Humana PDP Standard (currently with the second-most enrollment) raised its premium an average of 69%. The largest increase -- 89% -- is in United's Medicare Rx AARP Plan-Saver PDP, which as of July 2007 had over more 900,000 enrollees.

"The shift in premiums from year to year reflects a close calibration by the plan sponsors to maintain customer loyalty, remain competitively priced, and achieve profitability," said Bob Atlas, senior vice president of Avalere Health.

Avalere will continue to analyze Medicare drug benefit data as it is publicly released. Since the inception of the Medicare drug program, Avalere has used its DataFrame(R) database to track trends in drug pricing, plan strategy and structure, and the beneficiary experience. For more information on DataFrame(R) and Avalere's analytic capabilities, contact Brian Bruen, bbruen@avalerehealth.net.


'/>"/>
SOURCE Avalere Health
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HIV Prevalence In Ethiopian Women Greater Than National Average
2. Average Age of Diabetics Smaller in China
3. Delhis Morbidity Rate Nearly One-sixth of National Average
4. Medicare Drug Deadline not to be extended
5. House heads for Medicare drug vote
6. New Medicare Plan - Mixed Reaction among Pharmacists.
7. Medicare Data would help in Drug Validation
8. Medicare Queries Expected To Increase Over Time
9. Medicare to cover services provided by rural health care personnels.
10. Cancer test expenses taken up by Medicare
11. Nurse Practitioners Are Not Recognized By Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the impact of new federal healthcare regulations at the 7th annual Health IT ... Atlanta. , Andy Slavitt, acting administrator for the Centers for Medicare & Medicaid ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... 2016 , ... 'Tis the season for family, festivity, food and fun! Temptation ... season when eating healthy, staying active, and taking medication and doing daily foot health ... , "Shopping trips, parties and family gatherings can take their toll on our ...
(Date:12/6/2016)... ... December 06, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has announced the addition of ... safety and health training to public sector employees. , “The primary goal of ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward Buckingham MD , ... arrival of the newest Sciton laser in January 2017. The Halo is the ... and ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  BioAtla, LLC, a ... of Conditionally Active Biologic (CAB) antibody therapeutics, ... Group Company, Limited (Sinobioway) selected their first ... specific program candidates and the targeted indications ... and Sinobioway entered into a strategic collaboration ...
(Date:12/6/2016)... HASTINGS ON HUDSON, N.Y. , Dec. 6, ... anxiety, there,s now a reason to be hopeful. ... the way to a less anxious life. ... Robert Buck, the psychotherapist ... they represent a breakthrough approach to overcoming anxiety ...
(Date:12/5/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ... previously-announced cash tender offers (the "Offers") for the ... the "Notes"), approximately $2.6 billion in aggregate principal amount ... withdrawn on or prior to 5:00 p.m., ... 5, 2016 (the "Early Tender Deadline"). The Company ...
Breaking Medicine Technology: